Wake Receives First-Ever Approval for Psilocybin Microdose Study for Anxiety and Depression
In the first approval of its kind, Wake Network will study the effects of microdosing psilocybin on anxiety and depression.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
